EPISODE · Jul 7, 2021 · 1 MIN
Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients
from Rare Disease Discussions · host CheckRare Editors
Tim Miller, PhD, CEO, President, and Co-Founder of Forge Biologics, discusses the phase 1/2 RESKUE study which will evaluate FBX-101 for the treatment of Krabbe disease. This clinical trial is currently recruiting.Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
Embed this episode
NOW PLAYING
Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients
No transcript for this episode yet
Similar Episodes
No similar episodes found.